Speakers 2018

Patent Attorney, J A Kemp

Ravi has over 20 years of professional experience. He is known for his practical and commercial approach to patent work. He handles cases in both organic and inorganic chemistry, with particular expertise in the pharmaceutical field where he advises startup companies as well as medium-sized and large pharmaceutical companies.

In the pharmaceutical field, Ravi has acted in many high-profile conflicts, on drugs including doxorubicin, epirubicin, docetaxel, aclidinium, ebastine, plerixfor, betrixaben, aztreonam, heparin, risperidone and sofosbuvir. He has an impressive track record in defending patent estates protecting innovative pharmaceutical products. However, he is equally at home advising on freedom to operate and due diligence matters and drafting, filing and prosecuting patent applications at the European Patent Office (EPO) and elsewhere. Many of Ravi's clients have broad filing programmes, and Ravi routinely takes responsibility for filing pharmaceutical applications in over 40 countries.

In addition to his experience at the European Patent Office, Ravi is qualified as a litigator and holds the Higher Courts Litigation Certificate, which enables him to conduct IP litigation in the Intellectual Property Enterprise Court and the High Court and on appeal to the Court of Appeal and the Supreme Court.

Ravi is an overseas citizen of India, and is a frequent visitor to the country. He has specialist expertise in prosecuting Indian patent applications, and has experience of speaking at an opposition hearing at the Indian Patent Office.

Vice President
Sun Pharma

Ms Bharati Nadkarni is a pharmacist by profession with more than 17 years of work experience in IP and portfolio planning. Bharati joined Sun in 2000 in the IP team and have grown steadily at Sun, currently heading global IP litigation for Sun and also responsible for generic portfolio planning for regulated and emerging markets.

She has PhD in Pharmaceutical Chemistry and a post-graduate diploma in patent law & practice along with executive MBA.

Vice President of Intellectual Property and Product Portfolio Management
Glenmark Pharmaceuticals Limited

Mr. Taranpreet Singh Lamba is presently working as Vice President of Intellectual Property and Product Portfolio Management in Glenmark Pharmaceuticals Limited, Mumbai. He has more than 17 years of rich experience in the patent with specific focus in patentability aspect of Innovations, managing patent portfolios, life cycle management infringement matters and oppositions for various countries including India, Russia, Brazil, Mexico, Europe and US in the field of NCE, generics and biotechnology. He has handled various complex litigations and has done out of court settlements in various jurisdictions. Also responsible for making Product Portfolio for Glenmark Globally.

Taranpreet Singh Lamba has written articles on important intellectual property issues and has spoken at various National and International conferences on IP matters. He is a pharmacy graduate and has done M. Tech in Pharmaceutical Technology from NIPER and has further also done specialization in patent law.

Associate Director
Global IP Head
Intas Pharmaceuticals Ltd.

Dr. Alpesh Pathak is currently Global IP Head at Intas Pharmaceuticals Ltd. He works on a variety of intellectual property matters at global level, including IP due diligence of Biosimilar, IP activities for 351(k) filing, FTF Para IV filing for ANDA, Handling litigation across the globe and related activities, drafting and prosecution of patent applications, drafting and negotiation of intellectual property agreements with third parties, and due diligence analyses in supporting in-licensing and out-licensing activities.

Dr. Alpesh has authored a book Entitled “Protecting Patent Fundamentals” which is appreciated and well received by the patent professionals and major universities wherein patent is one of the value added subject in the respective technical discipline.

Prior to joining Intas, Dr. Alpesh has worked with some of the leading pharmaceutical companies like Alembic Ltd, Lupin Ltd., Zydus Cadila and Cadila Pharmaceuticals. Alpesh holds a PhD from The Sardar Patel University. Besides having PG diploma in Patent Law from Nalsar Uni, Hyderabad, he has undergone various specialized courses on US litigations and European patent practices.

He also is visiting faculty at Sardar Patel University and Gujarat Technical University (GTU).

Senior In-House Patent Attorney
Indoco Remedies Limited

Swati Veera is Senior In-House Patent Attorney at Indoco Remedies Limited. Ms. Veera has over 23 Years of experience in the field of IP, particularly Patents. Her experience includes conducting invalidity and non-infringement studies and rendering opinions; devising Hatch-Waxman litigation strategy and related issues, patent drafting, prosecution, patent portfolio management, patentability evaluation, and devising overall pharmaceutical patent strategies and implementing the same.

In her current role as Senior In-House Patent Counsel at Indoco Remedies Limited, Ms. Veera provides strategic expertise on a broad range of IP issues, advises senior management on IP issues that have legal implications, prepares legal opinions. Prior to joining Indoco, Ms. Veera worked as In-House Patent Counsel & Head of Patents Dept. at Piramal Healthcare Ltd. She has also worked as patent professional for leading Indian Pharmaceuticals including Sun Pharma. and Lupin.

Recently, Ms. Veera is recognised amongst “Top 100 Powerful Women in Law” by World Intellectual Property Forum. She has also been actively involved in spreading patent awareness among different functions of the Company through the designing and lecturing of In-house Patent training courses. She is a frequent speaker in IP programs organised in India.

B.E., LL.B., PGEMP Associate Vice President & Head - Intellectual Property Rights

Arshad Jamil is a senior Indian Patent Attorney with extensive experience in the legal and IP rights fields. Arshad is the chief IP counsel and global head of IP rights at Biocon Ltd, where he is responsible for the company’s patent and trademark filings and policy, abbreviated new drug application (ANDA) filings and handling US litigation for ANDAs and Biosimilars. Arshad manages Biocon’s IP portfolio of 1100+ patents and 650+ trademarks globally.

In his previous assignment, Arshad was a senior patent attorney at Sun Pharma, where he handled ANDA litigations, including Hatch Waxman settlements. He received his Bachelor of engineering (B.E.) from Mysore University in 1991 and his Bachelor of laws(LL.B.) from Meerut University (now Chaudhary Charan Singh University) in 1998. In 2014 he completed the SP Jain Institute of Management and Research postgraduate executive management programme.

Deputy Director
Patent Information Policy Planning Division, Japan Patent Office.

Yoshiyuki OSABE graduated from the University of Tokyo, Faculty of pharmaceutical science, and Graduate School in University of Tokyo (Master).

With majors in Intellectual Property and Biotechnology he joined the Japan Patent Office as a Patent Examiner in 2002.

Yoshiyuki is a visiting scientist in Catholic University of Leuven, Belgium, the Deputy Director in Bio-industry division, METI, Economist/ IP analyst in OECD and Administrative Judge in JPO.

He has authored, “Towards More Inclusive IP Analysis by Frontier Tools”, Intellectual Property Rights, which is edited by Sakthivel Lakshmana Prabu and Timmadonu Narasimman Kuppusami Suriyaprakasha.

His other authored works include Innovation Front and Technology Linkage, Business and Management Studies, 2016, Vol.2, No.1, pp 88-94 and Future Information Technology, Springer, Lecture Notes in Electrical Engineering Volume 309, 2014, pp 549-554

HGF Ltd.

Andy specialises primarily in patents in the fields of pharmaceuticals and chemistry on inventions relating to new chemical entities (NCEs), pharmaceutical formulations, methods of treatment, dosing regimens, medical devices, methods of manufacture, food and beverage products, materials chemistry and cosmetics products.

As well as drafting and prosecuting patent applications, Andy is also experienced in pharmaceutical patent litigation, having been involved in revocation proceedings at the UK High Court and also in the coordination of the pan-European revocation of a number of European patents covering pharmaceutical formulations and drug combinations.

Andy also manages the delivery of due diligence projects, requiring the formulation of complex prior art and FTO search strategies and advising on issues relating to patent term extensions, SPCs, regulatory data exclusivity, the enforceability of the patent portfolio (e.g. in terms of its patentability) and freedom to operate.

Andy’s client base includes International pharmaceutical companies, cosmetic companies and bulk chemical companies and UK Universities.

Andy graduated from The University of Nottingham with a first class MSc degree in Chemistry in 2006, joining the patent profession straight from University. He qualified as both a UK Chartered Patent Attorney and European Patent Attorney in 2010.

HGF Ltd.

Martyn advises clients on all aspects of contentious and non-contentious intellectual property law with a focus on intellectual property litigation.

He has been involved in numerous High Court actions in the fields of patents, trade marks, copyright, design rights and misuse of confidential information. He regularly acts for clients at all stages of litigation from pre-action issues right through to trial and appeal.

Martyn’s work often has an international aspect and he has considerable experience of coordinating legal teams in various jurisdictions.

Martyn’s clients are drawn from all sectors and include multinational companies, Universities and SMEs. He has been successful in a number of high profile patent infringement actions with technologies as diverse as pharmaceuticals (Glenmark Generics v GSK [2013] EWHC 148 (Pat) concerning GSK’s anti-malarial, Malarone), medical devices and complicated hydraulic devices (such as Triumph Actuation Systems Inc v Eaton Limited [2007] EWHC 1367 (Pat))

Martyn has extensive experience of the Intellectual Property Enterprise Court and in 2013 successfully acted for the defendants in the first trial before the new court (Manvers Engineering v Lubetech). He also has experience of entitlement, revocation and ownership disputes before the UK Intellectual Property Office.

Pellets Pharma
Head, Global IP & Strategic Planning

Mr Srikanta Patra with a deep industrial experience currently leads Intellectual Property Rights, Product portfolio and Strategic Planning at Pellets Pharma Limited.

He is an Indian Patent Agent and an accomplished IP strategist, inventor, innovation consultant and product portfolio specialist. He holds MS Pharm in Pharmaceutics from National Institute of Pharmaceutical Education and Research (NIPER) and a gold medallist in his graduation.

His areas of expertise include Intellectual Property Rights, Product Portfolio Management and Innovation Consultation. Prior to joining Pellets Pharma Limited, he was associated with Aizant Drug Research as Head of IP & Product portfolio management and was instrumental in identification and filing of several NCE-1 & Paragraph IV ANDA filling as well various 505 b (2) research. He also worked in Pharma Majors like Lupin and Cadila Healthcare. Mr. Patra is a registered Patent Facilitator at Indian Patent Office to help individual scientist and start-up.

Former Head - Legal, Ethics and Compliance
GSKConsumer ( JV of GSK & Novartis)

Sanjay is a Visionary, strategist & planner with multi-cultural experience in spearheading the entire Legal, Ethics & Compliance functions with hands-on expertise in Legal Operations, Compliance, corporate affairs, Privacy& Data protection, Digital business & Cyber Security and Legal disputes with focus on accomplishing organizational goals and objectives.

Starting his carier with Bhasin & Co LLP Associate, he has worked tierlessly in pharma sector offering efficient management advisory and effective management of Legal Operations & Global Ethics & Compliance.

He was Head – Legal, Piramal LifeSciences, General Counsel of Hetero Group before joining GSK Consumer. He has completed LLB and LLM from University of Delhi and has an international exposure and led several studies and letigations in countries like Germany, Brussels, Spain, Swiss apart from USA & UK.


Kirit is Director at Knovos (Previously known as Capital Novus) India. Kirit is a graduate from the prestigious NIT, Surat & Masters in Automation Programming from University of Pune. He is instrumental in setting up Knovos’ India operations from the scratch to developing global support system from India. He has over decade of experience in Designing innovative technology solution for eDiscovery & Information Governance. He has also successfully handled and assisted major Indian Generic Pharmaceuticals in their Hatch-Waxman Patent Litigations. He was pivotal in expanding Knovos operations in Tokyo, Paris and Germany. He was a special invitee by Gov. of Bhutan for providing solutions on Strategic Governance. He also played a key role making Knovos a Technology Partner for the Government of Uttarakhand, and assisted Hon’ble Chief Minister of Uttarakhand Shri Trivendra Singh Rawat to launch the CM Monitoring Dashboard - UTKARSH (Uttarakhand – Achieving Results in Systematic and Holistic way). UTKARSH is the only CM Dashboard in the country powered by Knovos’ Cascade – An Outcome based Budgeting & Performance Monitoring System. He played a key role in establishing strategic partnership in the Middle East region. He is also regularly invited for expert talk by various professional forums and universities.